FLUKIVER 5% W/V ORAL SUSPENSION

Страна: Ирландия

Язык: английский

Источник: HPRA (Health Products Regulatory Authority)

Активный ингредиент:

CLOSANTEL

Доступна с:

Elanco Animal Health, Eli Lilly and Company Limited

код АТС:

QP52AG09

ИНН (Международная Имя):

CLOSANTEL

дозировка:

5 %w/v

Фармацевтическая форма:

Oral Suspension

Тип рецепта:

LM: Licensed Merchant as defined in relevant national legislation

Терапевтическая группа:

Sheep

Терапевтические области:

closantel

Терапевтические показания :

Endoparasiticide

Статус Авторизация:

Authorised

Дата Авторизация:

2013-01-18

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Flukiver 5% w/v Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Closantel (as Clostanel sodium)
50 mg/ml
Excipients:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral suspension.
A white suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep and lambs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and control of adult and immature liver fluke,
haematophagous nematodes and larval stages of some
arthropods in sheep.
Liver fluke:
_Fasciola hepatica_ (average efficacy against 6 week immature stages
is 86%)
_Fasciola gigantica_
Haematophagous nematodes
_Haemonchus contortus_ (including benzimidazole resistant strains)
_Chabertia ovina_
_Gaigeria pachyscelis_
Arthropods
_Oestrus ovis_ (Sheep Nasal Bot Fly)
Ticks (_lxodes ricinus_) feeding on sheep at the time of treatment are
likely to produce fewer viable eggs.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_7_
_2_
_7_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk of development of resistance and could
ultimately result in ineffective therapy:
•
Too frequent and repeated use of anthelmintics from th